BetterScholar BetterScholar
13
Role
Title
Level Year L/R
🐜 Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States.
14 auth. R. Lawrence, C. Helmick, F. Arnett, R. Deyo, D. Felson, E. Giannini, S. Heyse, R. Hirsch, M. Hochberg, G. Hunder, ... M. Liang, S. Pillemer, V. Steen, F. Wolfe
11 1998
11
🐜
🦁 Preliminary definition of improvement in juvenile arthritis.
E. Giannini, N. Ruperto, A. Ravelli, D. Lovell, D. Felson, A. Martini
10 1997
10
🦁
🐜 Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group.
12 auth. D. Lovell, E. Giannini, A. Reiff, G. Cawkwell, E. Silverman, J. Nocton, ... L. Stein, A. Gedalia, N. Ilowite, C. Wallace, J. Whitmore, B. Finck
9 2000
9
🐜
🐢 Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis.
C. Wallace, N. Ruperto, E. Giannini
9 2004
9
🐢
🦁 Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group.
10 auth. E. Giannini, E. Brewer, N. Kuzmina, A. Shaikov, A. Maximov, I. Vorontsov, ... C. Fink, A. Newman, J. Cassidy, L. Zemel
9 1992
9
🦁
🐢 Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial
28 auth. N. Ruperto, D. Lovell, P. Quartier, E. Paz, N. Rubio-Pérez, C. Silva, C. Abud-Mendoza, R. Burgos-Vargas, V. Gerloni, J. Melo-Gomes, C. Saad-Magalhães, F. Sztajnbok, C. Goldenstein-Schainberg, M. Scheinberg, Immaculada Calvo Penades, ... M. Fischbach, J. Orozco, P. Hashkes, C. Hom, L. Jung, L. Lepore, S. Oliveira, C. Wallace, L. Sigal, A. Block, A. Covucci, A. Martini, E. Giannini
8 2008
8
🐢
🐬 American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis
C. Wallace, E. Giannini, Bin Huang, L. Itert, N. Ruperto
8 2011
8
🐬
🐢 A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis.
39 auth. N. Ruperto, D. Lovell, R. Cuttica, N. Wilkinson, P. Woo, G. Espada, C. Wouters, E. Silverman, Z. Balogh, M. Henrickson, M. Apaz, E. Baildam, A. Fasth, V. Gerloni, P. Lahdenne, ... A. Prieur, A. Ravelli, R. Saurenmann, M. Gamir, N. Wulffraat, L. Maródi, R. Petty, R. Joos, F. Zulian, D. McCurdy, B. Myones, K. Nagy, P. Reuman, I. Szer, S. Travers, A. Beutler, G. Keenan, Jason Clark, S. Visvanathan, A. Fasanmade, A. Raychaudhuri, A. Mendelsohn, A. Martini, E. Giannini
8 2007
8
🐢
🐜 International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease.
87 auth. D. Isenberg, E. Allen, V. Farewell, M. Ehrenstein, M. Hanna, I. Lundberg, C. Oddis, C. Pilkington, P. Plotz, D. Scott, J. Vencovský, R. Cooper, L. Rider, Frederick W. Miller, E. Adams, ... H. Alexanderson, N. Armentrout, Z. Argov, R. Barohn, S. Bowyer, H. Brunner, R. Burgos-Vargas, J. Callen, G. Cawkwell, P. Cherin, Yuen-Li Chung, H. Chwalińska-Sadowska, R. Cooper, M. Cronin, K. Danko, J. Davidson, Peter B. Dent, E. Dugan, B. Feldman, Richard Finkel, I. Torre, E. Genth, E. Giannini, G. Hengstman, J. Hicks, A. Huber, H. Huppertz, L. Imundo, Kent J. Johnson, J. Jorizzo, L. Kagen, J. Kissel, M. Klein‐gitelman, A. Kutzbach, B. Lang, M. Lassere, C. Lindsley, D. Lovell, S. Maillard, P. Malleson, A. Martini, T. Medsger, K. Murray, C. Oddis, L. Pachman, A. Paller, M. D. Perez, P. Plotz, D. Pongratz, A. Ravelli, A. Reed, R. Rennebohm, N. Ruperto, S. Rutkove, Clyde Ryder, J. Senécal, G. Serratrice, J. Serratrice, D. Sherry, K. Sivakumar, Yeong-Uk Song, R. Sontheimer, I. Targoff, M. Turner, Basiel van Engelen, M. Villalba, K. Vincent, V. Werth, P. White, J. Witter, R. Wortmann, S. Ytterberg
8 2004
8
🐜
🐢 Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis.
8 auth. D. Lovell, A. Reiff, N. Ilowite, C. Wallace, Y. Chon, Shao-Lee Lin, ... S. Baumgartner, E. Giannini
8 2008
8
🐢
🐜 Adalimumab with or without methotrexate in juvenile rheumatoid arthritis.
25 auth. D. Lovell, N. Ruperto, S. Goodman, A. Reiff, L. Jung, K. Jarošová, D. Němcová, R. Mouy, C. Sandborg, J. Bohnsack, D. Elewaut, I. Foeldvari, V. Gerloni, J. Rovenský, K. Minden, ... R. Vehe, L. Wagner Weiner, G. Horneff, H. Huppertz, Nancy Y. Olson, J. Medich, R. Carcereri-De-Prati, M. McIlraith, E. Giannini, A. Martini
8 2008
8
🐜
🐜 Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis.
22 auth. C. Wallace, E. Giannini, S. Spalding, P. Hashkes, K. O’neil, A. Zeft, I. Szer, S. Ringold, H. Brunner, L. Schanberg, ... R. Sundel, D. Milojevic, M. Punaro, P. Chira, B. Gottlieb, G. Higgins, N. Ilowite, Y. Kimura, S. Hamilton, Anne L. Johnson, Bin Huang, D. Lovell
8 2012
8
🐜
🐜 Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open-label, extended-treatment trial.
13 auth. D. Lovell, E. Giannini, A. Reiff, O. Jones, R. Schneider, J. Olson, L. Stein, A. Gedalia, N. Ilowite, C. Wallace, ... M. Lange, B. Finck, D. Burge
8 2003
8
🐜